Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

42.22
-0.1200-0.28%
Volume:330.78K
Turnover:14.06M
Market Cap:1.77B
PE:-15.53
High:43.33
Open:42.45
Low:41.81
Close:42.34
Loading ...
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Mar 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2025

Major Issues Report

Form 8-K - Current report
Jan 17, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 19, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 05, 2024

Major Issues Report

Form 8-K - Current report